Safety Profile Following Td Vaccination in Indonesian Pregnant Woman
NCT ID: NCT03383653
Last Updated: 2018-03-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
200 participants
OBSERVATIONAL
2017-08-29
2018-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Post Marketing Surveillance of Diphtheria Antitoxin (DAT)
NCT06053853
TDAP Safety in Pregnant Women
NCT02209623
Study on the Safety and Immunogenicity of Boostrix Vaccine in Pregnant Malian Women and Their Infants
NCT03589768
Pertussis Vaccine in Healthy Pregnant Women
NCT00707148
Seroprevalence of Bordetella Pertussis Antibodies and Anti-pertussis Antibody Response After a Single Dose of Tdap in Pregnant Thai Women
NCT03498300
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* 27-36 weeks of pregnancy
* Subject have been informed properly regarding the study and signed the informed consent form
* Subject will commit to comply with the instructions of the investigator and the schedule of the trial
Exclusion Criteria
18 Years
39 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Indonesian Vaccine Safety Advisory Committee
UNKNOWN
PT Bio Farma
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Julitasari Sundoro, MD
Role: PRINCIPAL_INVESTIGATOR
Indonesian Vaccine Safety Advisory Commitee
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Jakarta Provincial Ministry of Health
Jakarta, Jakarta Province, Indonesia
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Td0417
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.